Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes

por Friedland, Julie C., Smith, Donald L., Sang, Jim, Acquaviva, Jaime, He, Suqin, Zhang, Chaohua, Proia, David A.
Publicado 2013

The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer

por Smith, Donald L., Acquaviva, Jaime, Sequeira, Manuel, Jimenez, John-Paul, Zhang, Chaohua, Sang, Jim, Bates, Richard C., Proia, David A.
Publicado 2014

Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression

por HE, SUQIN, ZHANG, CHAOHUA, SHAFI, AYESHA A., SEQUEIRA, MANUEL, ACQUAVIVA, JAIME, FRIEDLAND, JULIE C., SANG, JIM, SMITH, DONALD L., WEIGEL, NANCY L., WADA, YUMIKO, PROIA, DAVID A.
Publicado 2012

Acquired MET Expression Confers Resistance to EGFR Inhibition In a Mouse Model of Glioblastoma Multiforme

por Jun, Hyun Jung, Acquaviva, Jaime, Chi, Dorcas, Lessard, Julie, Zhu, Haihao, Woolfenden, Steve, Bronson, Roderick T., Pfannl, Rolf, White, Forest, Housman, David E., Iyer, Lakshmanan, Whittaker, Charles A., Boskovitz, Abraham, Raval, Ami, Charest, Alain
Publicado 2011